Formation Bio News and Activities

Presence

Formation Bio develops medicines by combining drug development, data, and technology services. Its products and services include clinical development programs, software tools, and research support for patients, healthcare partners, and biopharma companies.

Formation Bio products and services overview:

Drug development
Clinical trials
Data platform
AI software
Research services

Revenue: ~$20 million

Employees: 300

Headquarters: New York, United States (USA)

Formation Bio is one of the...

Executives

View the org chart displaying its 25 main executives

Most searched biographies at Formation Bio

Popular executive movements at Formation Bio

Ashley Argiras has joined the company as Vice President of Quality (posted on March 25 2026).

Create your alert
to follow the executive moves at Formation Bio.

Biotechnology

Formation Bio has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

Tissium has just announced a $60 Million fundraising (posted on July 8 2026).
Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 8 2026).
Opthea has filed its IPO. Its stock ticker will be CYV. (posted on July 8 2026).